-
EP2321304
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2321304
| EP2321304 - THERAPEUTIC BETA-LACTAMS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.12.2013 Database last updated on 02.08.2024 | Most recent event Tooltip | 13.12.2013 | Application deemed to be withdrawn | published on 15.01.2014 [2014/03] | Applicant(s) | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | [N/P] |
| Former [2011/20] | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | Inventor(s) | 01 /
DINH, Danny, T. 11531 College Avenue Garden Grove CA 92840 / US | 02 /
OLD, David, W. 13771 Typee Way Irvine CA 92620 / US | 03 /
BURK, Robert, M. 1337 Cerritos Drive Laguna Beach CA 92651 / US | [2011/20] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE | [N/P] |
| Former [2011/20] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 09702401.2 | 14.01.2009 | [2011/20] | WO2009US30894 | Priority number, date | US20080022172 | 18.01.2008 Original published format: US 22172 | US20090352903 | 13.01.2009 Original published format: US 352903 | [2011/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009091764 | Date: | 23.07.2009 | Language: | EN | [2009/30] | Type: | A2 Application without search report | No.: | EP2321304 | Date: | 18.05.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.07.2009 takes the place of the publication of the European patent application. | [2011/20] | Search report(s) | International search report - published on: | EP | 21.01.2010 | Classification | IPC: | C07D409/06, C07D205/08, A61K31/397, A61P27/06, A61P27/02, A61P17/14 | [2011/20] | CPC: |
C07D409/06 (EP,US);
A61P17/14 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P43/00 (EP);
C07D205/08 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/20] | Title | German: | THERAPEUTISCHE BETA-LAKTAME | [2011/20] | English: | THERAPEUTIC BETA-LACTAMS | [2011/20] | French: | BÊTA-LACTAMINES À USAGE THÉRAPEUTIQUE | [2011/20] | Entry into regional phase | 10.08.2010 | National basic fee paid | 10.08.2010 | Designation fee(s) paid | 10.08.2010 | Examination fee paid | Examination procedure | 10.08.2010 | Amendment by applicant (claims and/or description) | 10.08.2010 | Examination requested [2011/20] | 12.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 14.11.2011 | Reply to a communication from the examining division | 01.08.2013 | Application deemed to be withdrawn, date of legal effect [2014/03] | 06.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/03] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 12.07.2011 | Fees paid | Renewal fee | 25.01.2011 | Renewal fee patent year 03 | 25.01.2012 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.01.2013 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2006121822 (ALLERGAN INC [US], et al) [A] 1-20 * page 3, line 16 - line 29 * * page 24 - page 29; compound - * * page 29, line 21 * * page 29, line 25 * * page 40 ** claims 1,14,15 * | by applicant | US4166452 | US4256108 | US4265874 | US5462968 | US5698598 | US6090847 | US6437146 | US6710072 | US7091231 | WO2006121822 |